Abu Dhabi Stem Cells Center Report issue

Academic/Hospital Phase 1 Phase 2

Organization Overview

First Clinical Trial
2020
NCT04473170
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Abu Dhabi Stem Cells Center | Abu Dhabi Stem Cells Center (ADSCC)

Active Ingredients

Drugs in Phase 2 Trials (1)

autologous non-hematopoietic peripheral blood stem cells (1 trial)

Drugs in Phase 1 Trials (1)

autologous peripheral blood mononuclear cells (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Coronavirus Infections (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 2
  • # of Trial APIs: 2